Top 5 Infectious Disease Stories: Week of February 17

This week, in efforts to navigate malaria with treatments, prevention, and the impact of climate change, the FDA is not requesting further trials for the investigational therapy cefepime-taniborbactam, sought details on its chemistry and manufacturing controls, examining immune responses to the COVID vaccine between cancer and non-cancer patients, influence of accessibility to HCV DAA in low and middle-income countries, and a study demonstrating the efficacy of HIV ART treatment in maintaining viral load suppression.

Source link

Daily Dose of Insights

Get a daily infusion of knowledge with our latest blog updates.

We don’t spam! Read our privacy policy for more info.


Please enter your comment!
Please enter your name here

Related articles

Children with RSV Post-COVID-19 Pandemic Needed More Support

JAMA Pediatrics: Children with RSV post-pandemic needed more support.Image credits: UnsplashIn the wake of the COVID-19 pandemic,...

The value of employee engagement

Unhealthy Employees Can Hurt a Healthy Bottom Line Unhealthy employees can have a profound impact on workforce productivity,...

Chicken Crust Pizza

Growing up pizza night was always a big hit in our house. I’ve since implemented it with...

Recent Salmonella Outbreaks Linked to Household Pet

The Centers for Disease Control (CDC) reported that Salmonella linked to pet bearded dragons has affected at...